Welgene Biotech Co.,Ltd.

6661

TW0006661002

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-06-06 pm EDT			5-day change	1st Jan Change
23.9 ^TWD	+1.70%		+4.82%	+6.94%

May. 09	Welgene Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 14	Welgene Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Welgene Biotech Co., Ltd. has filed an IPO.

October 06, 2017 at 12:00 am EDT

Welgene Biotech Co., Ltd. has filed an IPO. Security Name: Common Shares Security Type: Common Stock Securities Offered: 19,200,000

Latest news about Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-05	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-08	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-07	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-09	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-10	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-14	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-10	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-10	CI
Welgene Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-06	CI
Welgene Biotech Co., Ltd. has completed an IPO.	17-10-22	CI
Welgene Biotech Co., Ltd. has filed an IPO.	17-10-06	CI
Sygnis AG Signs Non-Exclusive Distribution Agreement with Welgene Biotech Co., Ltd	15-06-11	CI

Chart Welgene Biotech Co.,Ltd.

Duration

Period

More charts

WELGENE BIOTECH CO., LTD. is a Taiwan-based company mainly engaged in the provision of genetic testing services and products. The company focuses on deoxyribonucleic acid (DNA) microarray, Next Generation Sequencing and real-time quantitative polymerase chain reaction (PCR) and other testing technologies, which used in school research units, hospitals and biotech companies. The Company is also engaged in the trading of medical equipment. The company mainly operates in two business segments, including Biotechnology Testing segment and Equipment Trading segment. The Company mainly operates in Taiwan market.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
WELGENE BIOTECH CO.,LTD.	+6.94%	17.17M
MODERNA, INC.	+51.85%	57.87B
LONZA GROUP AG	+41.42%	40.25B
IQVIA HOLDINGS INC.	-5.25%	39.94B
CELLTRION, INC.	-5.16%	28.54B
ICON PUBLIC LIMITED COMPANY	+12.79%	26.4B
ALNYLAM PHARMACEUTICALS, INC.	-20.18%	19.33B
MEDPACE HOLDINGS, INC.	+30.88%	12.4B
BIO-TECHNE CORPORATION	+0.61%	12.23B
UNITED THERAPEUTICS CORPORATION	+25.06%	12.2B